Levaquin and Nilandron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levaquin (levofloxacin) and Nilandron (nilutamide). Common drug interactions include anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Levaquin and Nilandron. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

What is Nilandron?

Nilandron has active ingredients of nilutamide. eHealthMe is studying from 206 Nilandron users. Check the latest studies of Nilandron.



On Jul, 29, 2026

28 people who take Levaquin and Nilandron together, and have interactions are studied.

Levaquin and Nilandron drug interactions.

What are the common drug interactions of Levaquin and Nilandron, by gender? *:

female:

n/a

male:

  1. Anaemia (lack of blood)
  2. Osteonecrosis of jaw (death of bone of jaw)
  3. Dehydration (dryness resulting from the removal of water)
  4. Haematuria (presence of blood in urine)
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Urinary tract infection
  7. Cerebral infarction (less blood supply to brain resulting tissue damage)
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  10. Fall

What are the common drug interactions of Levaquin and Nilandron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal discomfort
  2. Abdominal distension
  3. Abdominal mass (localized enlargement or swelling in the human abdomen)
  4. Abscess jaw (tooth abscess or root abscess)
  5. Acute myocardial infarction (acute heart attack)
  6. Alanine aminotransferase increased
  7. Ammonia increased
  8. Anaemia (lack of blood)
  9. Anisocytosis (patient's red blood cells are of unequal size)
  10. Antithrombin iii decreased

50-59:

  1. Acute myocardial infarction (acute heart attack)
  2. Anaemia (lack of blood)
  3. Anisocytosis (patient's red blood cells are of unequal size)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Bladder obstruction
  6. Blood glucose increased
  7. Blood pressure systolic increased
  8. Bone density decreased
  9. Bone disorder
  10. Cardiac murmur (an heart sound in valve abnormality)

60+:

  1. Anaemia (lack of blood)
  2. Pain
  3. Spinal osteoarthritis (joint cartilage loss in spine)
  4. Cachexia (loss of weight)
  5. Cardiomegaly (increased size of heart than normal)
  6. Deformity (disfigurement)
  7. Fatigue (feeling of tiredness)
  8. Mass
  9. Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

What are the existing conditions these people have? *

  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 9 people, 32.14%
  2. Metastases To Bone (cancer spreads to bone): 8 people, 28.57%
  3. Bone Density Decreased: 5 people, 17.86%
  4. Bone Loss: 4 people, 14.29%
  5. Prostate Cancer: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Levaquin and Nilandron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levaquin and Nilandron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nilandron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nilandron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levofloxacin and nilutamide (the active ingredients of Levaquin and Nilandron, respectively), and Levaquin and Nilandron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: